By Denny Jacob
Elanco Animal Health will commercialize an avian flu vaccine for dairy cattle after reaching an agreement with Medgene.
The developer and manufacturer of pet and farm-animal products said on Tuesday that Medgene reported that its vaccine has met all requirements of the U.S. Agriculture Department's platform technology guidelines and is in the final stages of review for conditional license approval.
Elanco said a cattle vaccine will be critical to slow transmission between birds and cattle, a potential catalyst as a bird flu outbreak has roiled farms and sent egg prices soaring.
"As egg prices soar and milk production wanes in infected dairies, the need for new solutions to curb disease spread is evident," said Elanco Chief Executive Jeff Simmons.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
February 25, 2025 07:39 ET (12:39 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。